It sounds like the study's kick-off will definitely boost sales. "I think that women will be comforted by this," Dr Keith Eddleman, director of obstetrics at Mount Sinai Medical Center in New York, told Johnson in an AP article. "Most women are reluctant (to take anti-nausea medicine) just because of the stories they've heard and the perception that taking something in the first trimester can cause harm."
"There are very few drugs approved for use in the first trimester of pregnancy," Dr Jennifer Niebyl, a professor of obstetrics and gynecology at the University of Iowa, told Time Magazine on June 10, 2009.
"But this study could lead to metoclopramide getting approved to treat morning sickness because this is good data with big numbers," she said. "These findings may change practice and help people to be less hesitant to use the drug."
Dr Laura Riley, a Massachusetts General Hospital obstetrician and spokeswoman for the Society for Maternal Fetal Medicine, told Johnson women are far more cautious than doctors about medication. "For some who are on the fence, it'll allow them to take it."
The chairman of obstetrics and gynecology at St John's Health Center in Santa Monica, Dr James Moran, told the LA Times that he thinks the findings should be replicated but that he "wouldn't hesitate to use Reglan at all."
Infants heavily dosed
Reglan is also marketed off-label to nursing mothers to stimulate breast milk even though the medication guide warns women that the drug "can pass into breast milk and may harm your baby."
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).